Global Digital Biomanufacturing Market
Global Digital Biomanufacturing Market was valued at USD 16768 million in 2021 which expected to reach USD 56235 million by 2027, at a CAGR 8.47% from 2022-2027.
Digital biomanufacturing helps to enhanced the biological manufacturing by using computer aided design, verification & manufacture. It the digital technologies to improve the manufacturing process. Also, Digital biomanufacturing software improves asset dependability & availability while lowering maintenance costs.
Market Drivers
Increasing expansion of digital biomanufacturing plants is expected to boost the global market growth over the forecast period. Leading players are increasing their focus on expand the manufacturing process with innovative technologies to improve production process with research & development, paving the way for improved commercialization of essential new medicines for patients. This in turn to drive the growth of the digital biomanufacturing market. For instance, in October 2019, Sanofi, a global biopharmaceutical company introduced its digitally enabled continuous manufacturing facility in Framingham, Massachusetts.
Emerging role of digital biomanufacturing will positively influence the market growth. Digital biomanufacturing addresses unique aspects of biological activities & increase the data collection, monitoring, process control algorithms, automation, etc.
Market Restraint
Lack of awareness regarding the technologically advanced services in emerging economies are the factors that are likely to hinder the growth of global digital biomanufacturing market.
Market Segmentation
The Global Digital Biomanufacturing Market is segmented into type such as Manufacturing Technologies, Analytical and Process Control Technologies, Others. Further, market is segmented into application such as Bioprocess Optimization, Biomanufacturing Process Automation and Control, Others.
Regional Analysis
The Global Digital Biomanufacturing Market is segmented into five regions such as North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. Asia Pacific among regions is expected to exhibit the highest CAGR in the global digital biomanufacturing market. Due to the expansion of biopharmaceutical & pharmaceutical industry is likely driving the growth of digital biomanufacturing market in this region.
Key Players
Various key players are listed in the global digital biomanufacturing market including- ABB, Siemens, immersciobio, 3M, Sanofi, BIOMÉRIEUX, Agilent Technologies, Inc., GE Healthcare, Culture Biosciences, Cytiva, etc.
Market Taxonomy
By Type
By Application
Global Digital Biomanufacturing Market TOC
1 Introduction
1.1 Objective of the Study
1.2 Market definition
1.3 Market Scope
2 Research Methodology
2.1 Data Mining
2.2 Validation
2.3 Primary Interviews
2.4 List of Data Sources
3 Executive Summary
4 Global Digital Biomanufacturing Market Outlook
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
5 Global Digital Biomanufacturing Market, By Type
5.1 Y-o-Y Growth Comparison, By Type
5.2 Global Digital Biomanufacturing Market Share Analysis, By Type
5.3 Global Digital Biomanufacturing Market Size and Forecast, By Type
5.3.1. Manufacturing Technologies
5.3.2. Analytical and Process Control Technologies
5.3.3. Others
6 Global Digital Biomanufacturing Market, By Application
6.1 Y-o-Y Growth Comparison, By Application
6.2 Global Digital Biomanufacturing Market Share Analysis, By Application
6.3 Global Digital Biomanufacturing Market Size and Forecast, By Application
6.3.1 Bioprocess Optimization
6.3.2. Biomanufacturing Process Automation and Control
6.3.3. Others
7 Global Digital Biomanufacturing Market, By Region
7.1 Global Digital Biomanufacturing Market Share Analysis, By Region
7.2 Global Digital Biomanufacturing Market Share Analysis, By Region
7.3 Global Digital Biomanufacturing Market Size and Forecast, By Region
8 North America Digital Biomanufacturing Market Analysis and Forecast (2022-2027)
8.1 Introduction
8.2 North America Digital Biomanufacturing Market Share Analysis, By Type
8.3 North America Digital Biomanufacturing Market Size and Forecast, By Application
8.5 North America Digital Biomanufacturing Market Size and Forecast, By Country
8.5.1 U.S.
8.5.2 Canada
8.5.3 Mexico
9 Europe Digital Biomanufacturing Market Analysis and Forecast (2022-2027)
9.1 Introduction
9.2 Europe Digital Biomanufacturing Market Share Analysis, By Type
9.3 Europe Digital Biomanufacturing Market Size and Forecast, By Application
9.5 Europe Digital Biomanufacturing Market Size and Forecast, By Country
9.5.1 Germany
9.5.2 France
9.5.3 UK
9.54. Rest of Europe
10 Asia Pacific Digital Biomanufacturing Market Analysis and Forecast (2022-2027)
10.1 Introduction
10.2 Asia Pacific Digital Biomanufacturing Market Share Analysis, By Type
10.3 Asia Pacific Digital Biomanufacturing Market Size and Forecast, By Application
10.5 Asia Pacific Digital Biomanufacturing Market Size and Forecast, By Country
10.5.1 China
10.5.2 Japan
10.5.3 India
10.5.4. Rest of Asia Pacific
11 Latin America Digital Biomanufacturing Market Analysis and Forecast (2022-2027)
11.1 Introduction
11.2 Latin America Digital Biomanufacturing Market Share Analysis, By Type
11.3 Latin America Digital Biomanufacturing Market Size and Forecast, By Application
11.5 Latin America Digital Biomanufacturing Market Size and Forecast, Country
11.5.1. Brazil
11.5.2. Rest of Latin America
12 Middle East Digital Biomanufacturing Market Analysis and Forecast (2022-2027)
12.1 Introduction
12.2 Middle East Digital Biomanufacturing Market Share Analysis, By Type
12.3 Middle East Digital Biomanufacturing Market Size and Forecast, By Application
12.5 Middle East Digital Biomanufacturing Market Size and Forecast, By Country
12.65.1. Saudi Arabia
12.5.2. UAE
12.5.3. Egypt
15.5.4. Kuwait
12.5.5. South Africa
13 Competitive Analysis
13.1 Competition Dashboard
13.2 Market share Analysis of Top Vendors
13.3 Key Development Strategies
14Company Profiles
14.1 ABB
14.1.1 Overview
14.1.2 Offerings
14.1.3 Key Financials
14.1.4 Business Segment & Geographic Overview
14.1.5 Key Market Developments
14.1.6 Key Strategies
14.2. Siemens
14.2.1 Overview
14.2.2 Offerings
14.2.3 Key Financials
14.2.4 Business Segment & Geographic Overview
14.2.5 Key Market Developments
14.2.6 Key Strategies
14.3. immersciobio
14.3.1 Overview
14.3.2 Offerings
14.3.3 Key Financials
14.3.4 Business Segment & Geographic Overview
14.3.5 Key Market Developments
14.3.6 Key Strategies
14.4 3M
14.4.1 Overview
14.4.2 Offerings
14.4.3 Key Financials
14.4.4 Business Segment & Geographic Overview
14.4.5 Key Market Developments
14.4.6 Key Strategies
14.5 Sanofi
14.5.1 Overview
14.5.2 Offerings
14.5.3 Key Financials
14.5.4 Business Segment & Geographic Overview
14.5.5 Key Market Developments
14.5.6 Key Strategies
14.6 BIOMÉRIEUX
14.6.1 Overview
14.6.2 Offerings
14.6.3 Key Financials
14.6.4 Business Segment & Geographic Overview
14.6.5 Key Market Developments
14.6.6 Key Strategies
14.7 Agilent Technologies, Inc
14.7.1 Overview
14.7.2 Offerings
14.7.3 Key Financials
14.7.4 Business Segment & Geographic Overview
14.7.5 Key Market Developments
14.7.6 Key Strategies
14.8 GE Healthcare
14.8.1 Overview
14.8.2 Offerings
14.8.3 Key Financials
14.8.4 Business Segment & Geographic Overview
14.8.5 Key Market Developments
14.8.6 Key Strategies
14.9 Culture Biosciences
14.9.1 Overview
14.9.2 Offerings
14.9.3 Key Financials
14.9.4 Business Segment & Geographic Overview
14.9.5 Key Market Developments
14.9.6 Key Strategies
14.10.1 Overview
14.10.2 Offerings
14.10.3 Key Financials
14.10.4 Business Segment & Geographic Overview
14.10.5 Key Market Developments
14.10.6 Key Strategies
